2016 - Member of Academia Europaea
Member of the European Molecular Biology Organization (EMBO)
His primary scientific interests are in Cell biology, microRNA, Gene expression, Genetics and Genetic screen. His Cell biology study combines topics from a wide range of disciplines, such as RNA, Cell cycle, RNA interference, Gene and Chromosome passenger complex. His microRNA research is multidisciplinary, incorporating elements of Cancer, Cancer research, Downregulation and upregulation, Tensin and RNA-binding protein.
The RNA-binding protein study combines topics in areas such as Three prime untranslated region and Untranslated region. Reuven Agami combines subjects such as Small interfering RNA, CDC25A, Internal medicine, Matrigel and Gene silencing with his study of Gene expression. His Genetic screen research is multidisciplinary, relying on both Carcinogenesis, Nuclease protection assay and Endogeny.
His primary areas of study are Cell biology, Gene, Genetics, microRNA and Cancer research. His Cell biology research is multidisciplinary, incorporating perspectives in Gene expression, Protein biosynthesis, Regulation of gene expression, Transcription and Genetic screen. His Gene study integrates concerns from other disciplines, such as Molecular biology and Function.
His Genetics study deals with Computational biology intersecting with Epigenomics. His microRNA course of study focuses on Cervical cancer and Demethylating agent. His Cancer research research integrates issues from Cancer cell, Cancer, Breast cancer and Cell growth.
Reuven Agami spends much of his time researching Cell biology, Enhancer, Regulation of gene expression, Transcription and Transcription factor. His research integrates issues of Carcinogenesis, Messenger RNA, Gene, Protein biosynthesis and Ribosome in his study of Cell biology. His work in Carcinogenesis addresses subjects such as Oncogene, which are connected to disciplines such as Gene expression.
His Enhancer research incorporates themes from Cancer and Estrogen receptor alpha. The study incorporates disciplines such as Cancer research and DNA repair in addition to Cancer. His Regulation of gene expression study also includes fields such as
His main research concerns Cell biology, Gene, Senescence, Gene expression and Regulation of gene expression. His study in Cell biology is interdisciplinary in nature, drawing from both MRNA Sequencing, Proinflammatory cytokine and Ribosome. His Gene research is multidisciplinary, incorporating elements of Serine and Protein biosynthesis.
His Senescence study combines topics from a wide range of disciplines, such as Carcinogenesis, Oncogene, Ectopic expression, RNA interference and Gene silencing. His biological study spans a wide range of topics, including Terminator, Gene knockdown, Metastasis, Long non-coding RNA and Computational biology. His Regulation of gene expression study combines topics in areas such as CRISPR, Genome, Enhancer, Regulator and AP-1 transcription factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Thijn R. Brummelkamp;René Bernards;Reuven Agami.
Stable suppression of tumorigenicity by virus-mediated RNA interference.
Thijn R Brummelkamp;René Bernards;Reuven Agami.
Cancer Cell (2002)
A large-scale RNAi screen in human cells identifies new components of the p53 pathway
Katrien Berns;E. Marielle Hijmans;Jasper Mullenders;Thijn R. Brummelkamp.
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Huang Q;Gumireddy K;Schrier M;le Sage C.
Nature Cell Biology (2008)
Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation
Carlos le Sage;Remco Nagel;David A Egan;Mariette Schrier.
The EMBO Journal (2007)
RNA-binding protein Dnd1 inhibits microRNA access to target mRNA.
Martijn Kedde;Markus J. Strasser;Bijan Boldajipour;Joachim A.F. Oude Vrielink.
Interaction of c-Abl and p73α and their collaboration to induce apoptosis
Reuven Agami;Giovanni Blandino;Moshe Oren;Yosef Shaul.
Alternative cleavage and polyadenylation: extent, regulation and function
Ran Elkon;Alejandro P. Ugalde;Reuven Agami.
Nature Reviews Genetics (2013)
miR-148 targets human DNMT3b protein coding region.
Anja M. Duursma;Martijn Kedde;Mariette Schrier;Carlos le Sage.
MicroRNA regulation by RNA-binding proteins and its implications for cancer
Marieke van Kouwenhove;Martijn Kedde;Reuven Agami;Reuven Agami.
Nature Reviews Cancer (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: